We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note
Read MoreHide Full Article
The latest trading session saw Veeva Systems (VEEV - Free Report) ending at $222.72, denoting a -0.42% adjustment from its last day's close. The stock fell short of the S&P 500, which registered a loss of 0.17% for the day. Meanwhile, the Dow lost 0.39%, and the Nasdaq, a tech-heavy index, lost 0.05%.
Heading into today, shares of the provider of cloud-based software services for the life sciences industry had lost 5.61% over the past month, outpacing the Medical sector's loss of 6.9% and lagging the S&P 500's loss of 3.94% in that time.
The investment community will be closely monitoring the performance of Veeva Systems in its forthcoming earnings report. The company's upcoming EPS is projected at $1.74, signifying a 16% increase compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $727.99 million, up 11.94% from the year-ago period.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $7.31 per share and revenue of $3.05 billion, indicating changes of +10.76% and +11.03%, respectively, compared to the previous year.
Any recent changes to analyst estimates for Veeva Systems should also be noted by investors. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 5.5% higher. Veeva Systems presently features a Zacks Rank of #1 (Strong Buy).
Digging into valuation, Veeva Systems currently has a Forward P/E ratio of 30.6. This indicates a premium in contrast to its industry's Forward P/E of 24.21.
Meanwhile, VEEV's PEG ratio is currently 1.15. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical Info Systems industry had an average PEG ratio of 2.9 as trading concluded yesterday.
The Medical Info Systems industry is part of the Medical sector. This group has a Zacks Industry Rank of 44, putting it in the top 18% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note
The latest trading session saw Veeva Systems (VEEV - Free Report) ending at $222.72, denoting a -0.42% adjustment from its last day's close. The stock fell short of the S&P 500, which registered a loss of 0.17% for the day. Meanwhile, the Dow lost 0.39%, and the Nasdaq, a tech-heavy index, lost 0.05%.
Heading into today, shares of the provider of cloud-based software services for the life sciences industry had lost 5.61% over the past month, outpacing the Medical sector's loss of 6.9% and lagging the S&P 500's loss of 3.94% in that time.
The investment community will be closely monitoring the performance of Veeva Systems in its forthcoming earnings report. The company's upcoming EPS is projected at $1.74, signifying a 16% increase compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $727.99 million, up 11.94% from the year-ago period.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $7.31 per share and revenue of $3.05 billion, indicating changes of +10.76% and +11.03%, respectively, compared to the previous year.
Any recent changes to analyst estimates for Veeva Systems should also be noted by investors. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 5.5% higher. Veeva Systems presently features a Zacks Rank of #1 (Strong Buy).
Digging into valuation, Veeva Systems currently has a Forward P/E ratio of 30.6. This indicates a premium in contrast to its industry's Forward P/E of 24.21.
Meanwhile, VEEV's PEG ratio is currently 1.15. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical Info Systems industry had an average PEG ratio of 2.9 as trading concluded yesterday.
The Medical Info Systems industry is part of the Medical sector. This group has a Zacks Industry Rank of 44, putting it in the top 18% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.